Similarities and differences between SNDS and other claim databases On-Demand Webinar Similarities and differences between SNDS and other claim databases Amongst the real world data sources in Europe, the French Healthcare database SNDS is the…Certara2021年5月25日
Using Authoring Templates to Write the Right Way On-Demand Webinar Using Authoring Templates to Write the Right Way Creating submission-ready regulatory documents that are consistent in presentation, appropriate in content, and formatted to…Certara2021年5月25日
Overview of SNDS and the key working practices to access the database and ongoing SNDS developments On-Demand Webinar Overview of SNDS and the key working practices to access the database and ongoing SNDS developments Amongst the real world data sources in Europe, the French Healthcare database SNDS is the…Certara2021年5月25日
PBPK modeling approaches to assess risks associated with bioequivalence in drug development On-Demand Webinar PBPK modeling approaches to assess risks associated with bioequivalence in drug development In this webinar, Dr. Ioannis Loisios-Konstantinidis from Novartis, Switzerland discussed: Opportunities and challenges in conducting…Certara2021年5月19日
Evidence generation in Europe- How valuable is the French National administrative health data (SNDS) On-Demand Webinar Evidence generation in Europe- How valuable is the French National administrative health data (SNDS) Watch this presentation to learn • Overview of the SNDS and the key working practices…Certara2021年5月7日
The Wizard of Oligos: There’s no place like having a successful drug development program! オンデマンド・ウェビナー The Wizard of Oligos: There’s no place like having a successful drug development program! Oligonucleotide therapies— nucleic acid polymers with the potential to treat or manage a wide range…Certara2021年4月30日
The Promises and Pitfalls of Gene Therapy for Rare Diseases On-Demand Webinar 希少疾患に対する遺伝子治療の期待と落とし穴 The state of gene therapy faces much uncertainty as recent regulatory and clinical setbacks have…Certara2021年4月29日
Part 3: Oligonucleotide therapeutic development: Clinical pharmacology considerations On-Demand Webinar パート 3:Oligonucleotide therapeutic development: Clinical pharmacology considerations In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including…Certara2021年4月21日
Part 2: Oligonucleotide therapeutic development: Pre-clinical and translational considerations On-Demand Webinar パート 2:Oligonucleotide therapeutic development: Pre-clinical and translational considerations In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including…Certara2021年4月21日
Part 1: What are oligonucleotide therapeutics, and how do they work? オンデマンド・ウェビナー パート1:What are oligonucleotide therapeutics, and how do they work? In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including…Certara2021年4月21日